InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Strange Kevin T. Director active across 1 company, notably Inari Medical, Inc.. Aggregated, 4 disclosures have been published. History available since 1 October 2024. The latest transaction was disclosed on 4 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations